Global Fund Observer reports on new funding model progress

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 (.pdf) of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February (1/29). The second article reports on a consultation organized by the Communities Delegation on the Global Fund Board and the Global Network of People Living with HIV, writing, "[A]ttended by 31 community leaders and activists from national, regional and international networks of communities living with and affected by the three diseases," the communities consultation released a statement, which "said that the Global Fund should develop mechanisms 'to raise awareness, improve understanding of, and increase engagement of, communities prior to and during the transition to the NFM'" (1/29).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rutgers study sheds light on how bedaquiline fights drug-resistant tuberculosis